Two diabetes medications more beneficial in preventing major cardiovascular events

FHS
June 3, 2024
4:56 pm

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Study highlights benefits of exercise for both men and women

Females’ and males’ muscles differ in glucose and fatty acid handling – but regular physical activity quickly triggers similar beneficial metabolic changes in the muscles

August 16, 2024

TDR’s Top 5 Psychedelic Developments For The Week Of August 28

Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of August 28. Aside from presenting a synopsis of events, we provide

September 2, 2023

How were antibiotics used during the COVID-19 pandemic?

Researchers explores the application of antimicrobial stewardship in the antibiotic prescribing guidelines during the COVID-19 pandemic.

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.